LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $338,845 | -80.1% | 310,815 | -58.2% | 0.00% | -100.0% |
Q2 2023 | $1,702,491 | -2.6% | 743,737 | +3.4% | 0.00% | 0.0% |
Q1 2023 | $1,747,056 | +221607.6% | 719,182 | +74.2% | 0.00% | – |
Q4 2022 | $788 | -99.9% | 412,798 | -10.9% | 0.00% | – |
Q3 2022 | $1,111,000 | -10.3% | 463,188 | -30.3% | 0.00% | – |
Q2 2022 | $1,239,000 | -31.8% | 664,788 | -23.6% | 0.00% | -100.0% |
Q1 2022 | $1,818,000 | -40.3% | 869,611 | +12.5% | 0.00% | 0.0% |
Q4 2021 | $3,046,000 | +27.8% | 772,978 | +56.0% | 0.00% | 0.0% |
Q3 2021 | $2,383,000 | -4.1% | 495,438 | -8.5% | 0.00% | 0.0% |
Q2 2021 | $2,486,000 | +4261.4% | 541,655 | +3128.4% | 0.00% | – |
Q4 2020 | $57,000 | -10.9% | 16,778 | -49.0% | 0.00% | – |
Q1 2020 | $64,000 | +10.3% | 32,900 | +136.7% | 0.00% | – |
Q4 2019 | $58,000 | -84.4% | 13,900 | -55.3% | 0.00% | – |
Q1 2016 | $372,000 | -16.8% | 31,101 | -7.4% | 0.00% | – |
Q4 2015 | $447,000 | +23.8% | 33,602 | 0.0% | 0.00% | – |
Q3 2015 | $361,000 | +33.7% | 33,602 | 0.0% | 0.00% | – |
Q2 2015 | $270,000 | – | 33,602 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |